B. Dubicka
Evid Based Ment Health 2008 11: 110.
web only notes 11/4/110
Blinding was compromised in 64 cases, usually because the participant disclosed their CBT status to the assessor. There was no treatment group that did not involve medication switch, so the study cannot assess the effects of CBT in the absence of treatment switch. Use of paroxetine was stopped midway through the trial due to concerns about its efficacy and safety; only three patients were actively taking paroxetine at this time and they were removed from the study. Citalopram was substituted for paroxetine from this point.
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
